Jenny L. Pokorny - Concepedia

Concepedia

Author

Jenny L. Pokorny

Mayo Clinic ORCID

Also Known As

J POKORNY, J Pokorný, J. Pokorny, J.L. Pokorny, Jenny L Pokorny, Jenny L. Pokorny, Jenny Pokorny, L. Lei

87

Publications

1.6K

Citations

16

H-Index

32

Concepts

All Affiliations

Mayo Clinic WinnMed University of Minnesota Mayo Clinic in Arizona Mayo Clinic in Florida

JL

About

Jenny L. Pokorny is an author at Mayo Clinic specializing in cell biology, medicine, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	327
2	Cell Biology	5	5	327
3	Health Sciences	1	1	41
4	Cellular Physiology	1	1	14
5	Molecular Biology	1	1	306

Jenny L. Pokorny

×

17

Publications

1.6K

Citations

15

H-Index

	Year	Citations
WWP2 is an E3 ubiquitin ligase for PTEN Subbareddy Maddika, Sridhar Kavela, Neelam Rani, Nature Cell Biology E3 Ubiquitin LigaseMolecular BiologyProtein FunctionMolecular Regulation	2011	306
Establishment, Maintenance, and In Vitro and In Vivo Applications of Primary Human Glioblastoma Multiforme (GBM) Xenograft Models for Translational Biology Studies and Drug Discovery Brett L. Carlson, Jenny L. Pokorny, Mark A. Schroeder, Current Protocols in Pharmacology	2011	236
Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts Gaspar J. Kitange, Ann C. Mladek, Brett L. Carlson, Clinical Cancer Research	2012	148
The role of LAT1 in 18F-DOPA uptake in malignant gliomas Ryan S. Youland, Gaspar J. Kitange, Timothy E. Peterson, Journal of Neuro-Oncology Neuro-oncologyOncogenic AgentMedicinePathologyCancer Biology	2012	142
Delineation of<i>MGMT</i>Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma Shiv K. Gupta, Sani H. Kizilbash, Brett L. Carlson, JNCI Journal of the National Cancer Institute	2015	120
Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme Amanda Tivnan, Zaitun Zakaria, CaitrÃn O'Leary, Frontiers in Neuroscience Chemoprevention StrategyChemotherapy Drug ResponseImmunotherapeuticsHigh-grade GliomasGlioma	2015	119
Efflux Transporters at the Blood-Brain Barrier Limit Delivery and Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib (PD-0332991) in an Orthotopic Brain Tumor Model Karen E. Parrish, Jenny L. Pokorny, Rajendar K. Mittapalli, Journal of Pharmacology and Experimental Therapeutics	2015	96
Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents Sagar Agarwal, Rajendar K. Mittapalli, David M. Zellmer, Molecular Cancer Therapeutics	2012	92
The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma Jenny L. Pokorny, David Calligaris, Shiv K. Gupta, Clinical Cancer Research	2015	89
Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier Laurent Salphati, Timothy P. Heffron, Bruno Alicke, Clinical Cancer Research	2012	69

Page 1